• SENSEX 75,594.34
    -701.02 (--0.92%)
  • BANKNIFTY 51,597.35
    249.30 (+0.49%)
  • Tata Motors
    613.20 606.20(%)
  • Hindalco Inds.
    608.00 558.00(%)
  • Hind.Aeronautics
    4,205.05 3,045.95(%)
  • Reliance Industr
    1,192.85 1,156.00(%)
  • Mazagon Dock
    2,542.50 995.38(%)
  • Vedanta
    403.50 297.70(%)
  • Infosys
    1,451.50 1,359.10(%)
  • Interglobe Aviat
    5,150.65 5,187.00(%)
  • HDFC Bank
    1,842.20 1,880.00(%)
  • Bajaj Finance
    8,795.75 9,258.95(%)
  • ICICI Bank
    1,336.40 1,372.50(%)
  • Suzlon Energy
    55.00 37.95(%)
  • Vodafone Idea
    7.85 6.60(%)
  • TCS
    3,307.55 3,396.10(%)
  • Jio Financial
    222.30 198.60(%)
  • Angel One
    2,317.80 1,942.00(%)
  • O N G C
    225.70 215.20(%)
  • Kalyan Jewellers
    485.80 337.00(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • IndusInd Bank
    675.40 605.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Suven Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74679.0
  • ISIN : INE03QK01018
1,125.20 31 (2.79%)
  • As on 04 Apr 2025 (EOD)

  • Today’s Low

    1,096.60

  • Today’s High

    1,155.25

  • Open

    1,097.90

  • Perv Close

    1,094.65

  • 52W Low

    598.00

  • 52W High

    1,360.00

Key Indicators

  • P/E(TTM)

    101.83

  • Mar.Cap (₹Cr.)

    28,643.65

  • Div & Yield %

    0.00

  • Book Value(₹)

    86.66

  • Debt-Equity Ratio

    2.79

  • AGM Date

    03-Apr-2025

  • EPS

    11.05

  • P/E Ratio

    101.83

Financials Ratios

  • Debt-Equity Ratio

    0.04

  • Mar.Cap (₹Cr.)

    28,643.65

  • RONW (%)

    14.11

  • ROCE (%)

    18.69

Score Board

  • Equity (₹ in Cr.)

    25.46

  • BV (₹)

    86.70

  • Sales( ₹ in Cr.)

    1,024.99

  • NP (in Cr.)

    272.29

  • NP Var(%)

    -35.0

  • Div%

    0.0

  • CPS (₹)

    12.60

  • EPS (₹)

    10.70

  • Traded Value (₹ in Lakhs)

    28,644.92

  • 52 Week High

    1,360.00

  • 52 Week Low

    598.00

  • Price BSE

    1125.0

  • Price NSE

    1,125.00

  • Market Capital( in Cr.)

    28,644.92

  • P/C Ratio

    89.20

  • P/E Ratio

    105.20

  • Price Vs.BV

    10.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 1,024.99 1,330.08 1,320.22 1,009.72 833.79 0.00
Excise Duty 974.21 1,283.85 1,253.37 949.33 773.57 0.00
Net Sales 1,024.99 1,330.08 1,320.22 1,009.72 833.79 0.00
Other Income 55.09 44.55 187.79 14.24 18.12 0.00
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 1,080.09 1,374.63 1,508.01 1,023.96 851.91 0.00
EXPENDITURE :
Raw Materials 974.21 1,283.85 1,253.37 949.33 773.57 0.00
Power & Fuel Cost 974.21 1,283.85 1,253.37 949.33 773.57 0.00
Employee Cost 126.88 108.58 100.48 76.23 65.10 0.00
Other Manufacturing Expenses 17.75 13.50 13.46 11.13 8.41 0.00
Selling & Administrative Expenses 40.43 45.24 53.99 46.10 45.60 0.02
Miscellaneous Expenses 17.75 13.50 13.46 11.13 8.41 0.00
Less : Pre-operative Expenses Capitalised :
Total Expenditure 671.31 795.24 785.56 609.98 494.32 0.02
Operating Profit 127.78 171.65 173.19 133.79 103.84 0.00
Interest 7.43 12.75 6.23 9.14 18.66 0.00
Gross Profit 408.77 579.39 722.45 413.98 357.59 -0.02
Depreciation 48.79 43.10 39.10 31.64 23.51 0.00
Profit Before Tax 408.77 579.39 722.45 413.98 357.59 -0.02
Tax 98.14 144.63 157.63 101.54 88.81 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 6.59 4.34 6.72 3.62 -1.30 0.00
Reported Net Profit 304.82 432.60 558.10 308.65 270.08 -0.02
Extraordinary Items 408.77 579.39 722.45 413.98 357.59 -0.02
Adjusted Net Profit 304.82 432.60 558.10 308.65 270.08 -0.02
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 152.74 127.28 50.91 63.64 0.00
P & L Balance carried down 304.82 432.60 558.10 308.65 270.08 -0.02
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 600.00 500.00 200.00 500.00 0.00
Dividend Per Share(Rs) 0.00 6.00 5.00 2.00 5.00 0.00
Earnings Per Share-Unit Curr 11.97 16.99 21.92 12.12 10.61 -2.20
Book Value 0.00 152.74 127.28 50.91 63.64 0.00
Book Value(Adj)-Unit Curr 0.00 152.74 127.28 50.91 63.64 0.00

Shareholding Pattern

  • Promoter Group

    50.10%

  • Public Share Holding

    49.90%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 127,539,592 50.10 127,539,592 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 127,539,592 50.10 127,539,592 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 30,148 0.01 30,148 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 211 0.00 211 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 27,592,998 10.84 27,592,998 152
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 8,148,617 3.20 8,148,617 5
Mutual Funds / UTI 33,486,513 13.15 33,450,513 27
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 824,936 0.32 824,936 14
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 70,083,423 27.53 70,047,423 201
2] Non Institution
Bodies Corporate 28,442,617 11.17 28,438,617 695
Clearing Members 3,572 0.00 3,572 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,390,317 0.94 2,390,317 2,627
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 790,336 0.31 789,836 1,282
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 703,799 0.28 703,799 2
Individuals holding nominal share capital up to Rs. 1 lakh 24,259,975 9.53 23,921,904 79,389
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,687 0.00 2,687 6
Others 348,638 0.14 348,638 1
Sub Total 56,941,941 22.37 56,599,370 84,008
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 254,564,956 100.00 254,186,385 84,210

Company Background

Suven Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Suven Pharmaceuticals Ltd
  • BSE Code : 74679.0
  • ISIN : INE03QK01018

  • Incorporation Year

    2018

  • Registered Office

    8-2-334 SDE Serene Chambers
    3 Floor Avenue 7 Road No 5, Hyderabad,
    Telangana-500034

  • Telephone

    91-40-23549414/1142/3311

  • FAX

    91-40-23541152

  • Chairman

    VIVEK SHARMA

  • Managing Director

    Venkatanaga Kali Vara Prasad Raju Vetukuri

  • Company Secretary

    Kundan Kumar Jha

  • Auditor

    Karvy & Co/Walker Chandiok & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Suven Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Suven Pharma 1,125.25 1,080.09 1,024.99 101.83 18.82
Abbott India 29,940.35 6,097.18 5,848.91 47.68 44.71
Astrazeneca Phar 8,092.00 1,330.33 1,295.53 208.61 33.26
P & G Health Ltd 5,295.80 1,166.89 1,151.26 37.16 39.76
Glaxosmi. Pharma 2,857.90 3,530.73 3,407.25 56.83 44.44
Cipla 1,495.15 17,645.00 16,574.34 25.63 20.10
Amrutanjan Healt 666.30 437.58 421.23 39.06 20.84
Fermenta Biotec. 305.85 315.24 307.09 28.99 4.10
Guj. Themis Bio. 282.25 174.19 169.82 58.44 44.82
Bliss GVS Pharma 126.20 638.96 605.46 28.88 11.19
Ambalal Sarabhai 40.33 11.70 3.81 17.24 1.92